Kymera Therapeutics
KYMR
#3656
Rank
NZ$4.99 B
Marketcap
$77.06
Share price
3.38%
Change (1 day)
133.63%
Change (1 year)

Kymera Therapeutics (KYMR) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.94 Billion

According to Kymera Therapeutics's latest financial reports the company has NZ$0.94 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Kymera Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.59 B-7.57%
2022-12-31NZ$0.64 B-0.99%
2021-12-31NZ$0.64 B57.78%
2020-12-31NZ$0.41 B200.65%
2019-12-31NZ$0.13 B121.98%
2018-12-31NZ$61.51 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.49 B-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA